Skip to ContentSkip to Navigation
How to find us drs. A.R. (Arno) Bourgonje


Biomarkers reflecting extracellular matrix turnover and inflammation can be used to monitor disease activity and treatment response in patients with Crohn's disease undergoing infliximab induction therapy

Clinical implications of vitamin B12 as redox-active cofactor

COVID-19: immunopathology, pathophysiological mechanisms, and treatment options

N-acetylcysteine (NAC) and Hydrogen Sulfide (H2S) in Coronavirus Disease 2019 (COVID-19)

Safety and drug survival of methotrexate versus tioguanine after failure of conventional thiopurines in patients with Crohn's disease

Serological biomarkers of type III and IV collagen remodeling predict and monitor infliximab treatment response in patients with Inflammatory Bowel Disease

Systemic Oxidative Stress, Aging and the Risk of Cardiovascular Events in the General Female Population

The effect of phenotype and genotype on the plasma proteome in patients with Inflammatory Bowel Disease

Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options

Type I collagen degradation fragments and type IV collagen formation/degradation ratio are serological biomarkers for stricturing (Montreal B2) Crohn's disease

Read more